Cooperative Agreement NU66IP000683

Award Date 9/29/23
Completion Date 9/28/25
Dollars Obligated $800K
Awarding Federal Agency
Office of Financial Resources
Federal Grant Program
93.323
Assistance Type
Cooperative Agreement
Place of Performance
Washington, DC, USA
Similar Awards
This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC), under the Epidemiology and Laboratory Capacity for Infectious Diseases (CFDA 93.323) program, provides $6,065,798 to the American Immunization Registry Association (AIRA) over a 5-year period from August 1, 2024 to July 31, 2029. The purpose of this award is to enhance immunization information systems and strengthen public health infrastructure for detecting, responding to, preventing, and controlling...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $343,302 Cooperative Agreement to the Connecticut Department of Public Health (DPH) under the Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects program (CFDA 93.185). The funding supports critical core capacity for DPH programs and the State Public Health Laboratory (SPHL) to enhance state and local health capacity in responding to new infectious disease...
This Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research) will fund a research study to increase RSV vaccine uptake among Latino older adults. The $2,058,402 award to the Regents of the University of California, San Francisco aims to adapt a community-based "Motivate, Vaccinate, Activate" intervention, including CHW counseling and text message nudges, to address trust, knowledge, and...
This $4,500,000 Cooperative Agreement award, funded by the Centers for Disease Control and Prevention (CDC) under the Emerging Infections Programs (CFDA 93.317), will establish a nationwide cohort of blood donors to estimate the burden of respiratory viruses and characterize the associated immune response. The primary awardee, Vitalant Research Institute (VRI), will lead the effort in collaboration with sub-awardees Westat, Inc. and the American Red Cross. Key activities include developing and...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the federal Child Health and Human Development Extramural Research program (CFDA 93.865), provides $220,000.00 to Seattle Children's Hospital to develop and evaluate the "Presumptively Initiating Vaccines and Optimizing Talk for Inpatients (PIVOT-IN)" intervention. The goal of this project is to improve routine vaccination of vaccine-eligible children during their hospital stays....
This $2,146,691 Project Grant, awarded by the National Institute of Child Health and Human Development under the Child Health and Human Development Extramural Research program (CFDA 93.865), will fund a study on the effects of the prenatal RSV prefusion F protein-based (RSVpreF) vaccine on neonatal, lactation, and child health outcomes. The study will leverage electronic health record data and state immunization information systems across four large health systems to examine a cohort of up to...
This $5,600,000 Cooperative Agreement award from the U.S. Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) aims to strengthen immunization program implementation in sub-national consequential geographies. The prime awardee, Interchurch Medical Assistance, Inc., is a faith-based global nonprofit organization that provides sustainable solutions to health-related problems in developing countries. The award, with a performance period from...
This $799,904 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (CFDA 93.323) program supports the "ARISE COORDINATING AND COLLABORATING CENTERS FOR THE STUDY OF VACCINE HESITANCY AND UPTAKE" project at New York University (NYU) School of Medicine. The project aims to enhance public health infrastructure for detecting, responding to, preventing, and controlling infectious...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $282,526 Cooperative Agreement to the South Carolina Department of Public Health (SCDPH) under the Immunization Cooperative Agreements (CFDA 93.268) program. The award, effective August 1, 2024 through July 31, 2029, will support SCDPH in establishing and maintaining preventive health service programs to immunize individuals against vaccine-preventable diseases such as measles, poliomyelitis,...
This Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research) provides $2,065,719 to New York University to conduct a community-based behavioral intervention study. The goal is to increase COVID-19 and influenza vaccination rates among African American/Black and Latino persons, populations that have experienced disparities in vaccination uptake. The study will test the impact of four intervention...

ELIMINATING BARRIERS TO IMMUNIZATION THROUGH STATE INTERAGENCY AND COMMUNITY COLLABORATION - PROJECT ABSTRACT: CDC-RFA-IP-23-0002 IMMUNIZATION BARRIERS IN THE UNITED STATES: TARGETING MEDICAID PARTNERSHIPS NASHP, ACADEMYHEALTH, AIM AND AIRA PROJECT: ELIMINATING BARRIERS TO IMMUNIZATION THROUGH STATE INTERAGENCY AND COMMUNITY COLLABORATION DESPITE ENHANCED COVERAGE THROUGH MEDICAID AND THE VACCINES FOR CHILDREN PROGRAM, LOW-INCOME CHILDREN, ADOLESCENTS, ADULTS, AND PREGNANT PEOPLE CONTINUE TO HAVE LOWER ESTIMATED VACCINATION RATES THAN THOSE ABOVE POVERTY LEVEL. INTERAGENCY AND MULTI-STAKEHOLDER COLLABORATION WITH MEDICAID PROGRAMS CAN STRENGTHEN THEIR ABILITY TO UNDERSTAND AND ADDRESS BARRIERS TO IMPROVING IMMUNIZATION RATES AMONG THESE VULNERABLE POPULATIONS, INCLUDING IMMUNIZATION INFORMATION SYSTEMS INTEROPERABILITY, PROVIDER SCOPE OF PRACTICE, AMONG OTHERS. NOW, FACING DOCUMENTED COVID-19 FATIGUE AND AN INCREASINGLY HOSTILE IMMUNIZATION ENVIRONMENT, IT WILL BE ESPECIALLY VALUABLE TO ADDRESS THE POTENTIAL HEALTH IMPLICATIONS FROM DELAYED VACCINATION SCHEDULES AND WELL-CHILD VISITS. NATIONAL ACADEMY FOR STATE HEALTH POLICY (NASHP) AND ACADEMYHEALTH, IN POTENTIAL PARTNERSHIP WITH THE ASSOCIATION OF IMMUNIZATION MANAGERS (AIM) AND THE AMERICAN IMMUNIZATION REGISTRY ASSOCIATION (AIRA), PROPOSE FORMING A NEW "VACCINE INFORMATION SHARING AND EDUCATION RESOURCE" NETWORK (VISER NETWORK). WE WILL BUILD ON OUR PREVIOUSLY CDC-FUNDED PROJECT WITH TWO NEW PROPOSED WORKSTREAMS. THIS PROPOSAL AIMS TO ENGAGE WITH VACCINE ACCESS COOPERATIVE (VAC) MEMBERS, THE MEDICAID MEDICAL DIRECTORS NETWORK (MMDN), AND OTHER MEDICAID STAKEHOLDERS USING A MULTI-FACETED STRATEGY TO ENHANCE COLLABORATIVE IMMUNIZATION EFFORTS ACROSS PERTINENT STATE AGENCIES AND IMPROVE IMMUNIZATION RATES FOR ALL MEDICAID COVERED LIVES. LEVERAGING PARTNERSHIPS TO IMMUNIZE AGAINST VACCINE-PREVENTABLE RESPIRATORY DISEASE: VISER LEARNING NETWORK: BUILDING ON MOMENTUM AND PARTNERSHIPS GENERATED THROUGH PREVIOUS REGIONAL VAC MEETINGS, THE VISER LEARNING NETWORK WILL ENGAGE CROSS-AGENCY AND MULTI-SECTOR VAC PARTICIPANTS IN AN ONGOING LEARNING NETWORK FOCUSED ON DISSEMINATING EVIDENCE-BASED INFORMATION, SHARING PROMISING AND BEST PRACTICES TO IMPROVE VACCINATION RATES, AND DISCUSSING EMERGING ISSUES RELATED TO VACCINE-PREVENTABLE RESPIRATORY CONDITIONS. LEVERAGING THIS NEW COALITION OF PARTNERS WITH RENEWED ENERGY AND INTEREST IN IMPROVING VACCINATION RATES, THE VACCINE-PREVENTABLE RESPIRATORY DISEASE LEARNING NETWORK WILL HOLD MONTHLY LEARNING NETWORK CALLS THAT PRESENT TIMELY INFORMATION AND SHARE STRATEGIES TO IMPROVE VACCINATION RATES FOR VACCINE-PREVENTABLE RESPIRATORY CONDITIONS ACROSS THE LIFESPAN. TECHNICAL ASSISTANCE TO ADDRESS BARRIERS TO INFORMATION EXCHANGE AND COLLABORATION BETWEEN MEDICAID PROGRAMS AND PUBLIC HEALTH: IN-DEPTH POLICY CONSULTATIONS: THE PROJECT TEAM WILL FOCUS ON ADDRESSING POLICY, TECHNICAL, AND ORGANIZATIONAL BARRIERS TO INFORMATION EXCHANGE BETWEEN STATE MEDICAID INFORMATION SYSTEMS AND IIS. IMPROVING BI-DIRECTIONAL INFORMATION EXCHANGE BETWEEN MEDICAID AND IMMUNIZATION PROGRAMS IS CRITICAL TO UNDERSTANDING AND ADDRESSING VACCINATION COVERAGE AND GAPS AND SUPPORTING IIS INFRASTRUCTURE THROUGH FEDERAL MATCHING FUNDS. THE VISER NETWORK WILL LAUNCH AN OPPORTUNITY FOR UP TO SIX CROSS-AGENCY STATE TEAMS (TWO CYCLES OF THREE STATES EACH) TO RECEIVE IN-DEPTH TECHNICAL ASSISTANCE ON SPECIFIC GOALS RELATED TO CONNECTING IIS AND MEDICAID PROGRAMS TO SHARE IMMUNIZATION DATA BETWEEN AGENCIES AND SUPPORT IIS INFRASTRUCTURE.

Posted 8/24/23, 12:00 AM